triple negative breast cancer tnbc cell line bt549 (ATCC)
Structured Review
Triple Negative Breast Cancer Tnbc Cell Line Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2962 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+bt549/BT-549/10__1091_slash_mbc__e25___07___0340-244-2-14
Average 99 stars, based on 2962 article reviews
Images
Related Articles
other:Article Title: Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles. Article Snippet: Contents lists available at ScienceDirect Journal of Controlled Release j ourna l homepage: www.e lsev ie r .com/ locate / j conre l Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles Yang Liu a, Yan-Hua Zhu a, Cheng-Qiong Mao a, Shuang Dou a,b, Song Shen a, Zi-Bin Tan a, Jun Wang a,b,c,⁎ a CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui 230027, China b Hefei National Laboratory for Physical Sciences at Microscale, Hefei, Anhui 230027, China c High Magnetic Field Laboratory of CAS, University of Science and Technology of China, Hefei, Anhui 230026, China ⁎ Corresponding author at: School of Life Sciences, Unive of China, Hefei, Anhui 230027, China.. Tel.. : +86 551 6360 E-mail address: jwang699@ustc.edu.cn (J. Wang). http://dx.doi.org/10.1016/j.jconrel.2014.07.001 0168-3659/© 2014 Elsevier B.V. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 27 November 2013 Accepted 2 July 2014 Available online 10 July 2014 Keywords: Triple-negative breast cancer Synthetic lethality siRNA delivery Cationic lipid assisted nanoparticle Cyclin-dependent kinase 1 There is no effective clinical therapy yet for triple-negative breast cancer (TNBC) without particular human epidermal growth factor receptor-2, estrogen and progesterone receptor expression. |
